TY - JOUR
T1 - Improvement within 2 weeks and later treatment outcomes in patients with depressive disorders
T2 - The CRESCEND study
AU - Kim, Jae Min
AU - Kim, Seon Young
AU - Stewart, Robert
AU - Yoo, Joon An
AU - Bae, Kyung Yeol
AU - Jung, Sung Won
AU - Lee, Min-Soo
AU - Yim, Hyeon Woo
AU - Jun, Tae Youn
PY - 2011/3/1
Y1 - 2011/3/1
N2 - Background: Although antidepressants are conventionally given for 4-6 weeks before deciding on response, several reports suggest that early improvement predicts later outcomes. In a naturalistic national cohort study, we sought to investigate the predictive value of early improvement on Hamilton Depression Rating Scale (HAMD) score for later outcomes (depression (HAMD), anxiety (HAMA), global severity (CGI-s) and functioning (SOFAS)), as well as socio-demographic and clinical correlates of early improvement. Methods: Participants were recruited from 18 hospitals across South Korea. All met DSM-IV criteria for depressive disorders, scored ≥ 14 on the HAMD and received antidepressant treatment for up to 12 weeks. Treatment was naturalistic in that each clinician freely decided the types, doses, and regimes of antidepressant and concomitant medications. Early improvement was defined as a reduction in HAMD score of ≥ 20% compared with baseline within 2 weeks of treatment. Later treatment outcomes were measured at 4, 8, and 12 weeks. Results: In a recruited sample of 568 patients, early improvement predicted 12 week treatment outcomes with high sensitivity and high negative predictive values. The predictive values for HAMD and HAMA 12-week responses were higher compared to CGI-s and SOFAS responses. Early improvement was associated with higher monthly income, baseline lower anxiety and higher functioning levels. The patients with early improvement more frequently received antidepressant monotherapy. Limitations: The study was observational, and the treatment modality was naturalistic. Conclusions: Early antidepressant improvement strongly predicted later outcomes, and was associated with higher income, lower anxiety, and higher function.
AB - Background: Although antidepressants are conventionally given for 4-6 weeks before deciding on response, several reports suggest that early improvement predicts later outcomes. In a naturalistic national cohort study, we sought to investigate the predictive value of early improvement on Hamilton Depression Rating Scale (HAMD) score for later outcomes (depression (HAMD), anxiety (HAMA), global severity (CGI-s) and functioning (SOFAS)), as well as socio-demographic and clinical correlates of early improvement. Methods: Participants were recruited from 18 hospitals across South Korea. All met DSM-IV criteria for depressive disorders, scored ≥ 14 on the HAMD and received antidepressant treatment for up to 12 weeks. Treatment was naturalistic in that each clinician freely decided the types, doses, and regimes of antidepressant and concomitant medications. Early improvement was defined as a reduction in HAMD score of ≥ 20% compared with baseline within 2 weeks of treatment. Later treatment outcomes were measured at 4, 8, and 12 weeks. Results: In a recruited sample of 568 patients, early improvement predicted 12 week treatment outcomes with high sensitivity and high negative predictive values. The predictive values for HAMD and HAMA 12-week responses were higher compared to CGI-s and SOFAS responses. Early improvement was associated with higher monthly income, baseline lower anxiety and higher functioning levels. The patients with early improvement more frequently received antidepressant monotherapy. Limitations: The study was observational, and the treatment modality was naturalistic. Conclusions: Early antidepressant improvement strongly predicted later outcomes, and was associated with higher income, lower anxiety, and higher function.
KW - Depression
KW - Early improvement
KW - Korea
KW - Predictor
KW - Remission
KW - Response
UR - http://www.scopus.com/inward/record.url?scp=79851514701&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79851514701&partnerID=8YFLogxK
U2 - 10.1016/j.jad.2010.09.007
DO - 10.1016/j.jad.2010.09.007
M3 - Article
C2 - 20875918
AN - SCOPUS:79851514701
SN - 0165-0327
VL - 129
SP - 183
EP - 190
JO - Journal of Affective Disorders
JF - Journal of Affective Disorders
IS - 1-3
ER -